You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 15, 2025

List of Excipients in API CYCLOSPORINE


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing CYCLOSPORINE

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Allergan Inc RESTASIS MULTIDOSE cyclosporine 0023-5301 CARBOMER COPOLYMER TYPE A
Allergan Inc RESTASIS MULTIDOSE cyclosporine 0023-5301 CASTOR OIL
Allergan Inc RESTASIS MULTIDOSE cyclosporine 0023-5301 GLYCERIN
Allergan Inc RESTASIS MULTIDOSE cyclosporine 0023-5301 POLYSORBATE 80
Allergan Inc RESTASIS MULTIDOSE cyclosporine 0023-5301 SODIUM HYDROXIDE
Allergan Inc RESTASIS MULTIDOSE cyclosporine 0023-5301 WATER
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for CYCLOSPORINE

Excipient focus: .ALPHA.-TOCOPHEROL

Excipient focus: .ALPHA.-TOCOPHEROL, DL-

Excipient focus: 1,1,1,2,2,3,3,4,4-NONAFLUORONONANE

Excipient focus: ALCOHOL

Excipient focus: ALUMINUM OXIDE

Excipient focus: AMMONIA

Excipient focus: BUTYL ALCOHOL

Excipient focus: CAPRYLOCAPROYL POLYOXYLGLYCERIDES 8

Excipient focus: CARBOMER COPOLYMER TYPE A

Excipient focus: CASTOR OIL

Excipient focus: CETALKONIUM CHLORIDE

Excipient focus: COCHINEAL

Excipient focus: CORN GLYCERIDES

Excipient focus: CORN OIL

Excipient focus: D&C YELLOW NO. 10

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C RED NO. 40

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GELATIN

Excipient focus: GLYCERIN

Excipient focus: GLYCERYL MONOCAPRYLATE

Excipient focus: GLYCERYL MONOLINOLEATE

Excipient focus: GLYCINE

Excipient focus: HYDROCHLORIC ACID

Excipient focus: HYDROLYZED PORCINE COLLAGEN

Excipient focus: HYPROMELLOSE 2910

Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES

Excipient focus: METHYL ALCOHOL

Excipient focus: NONCRYSTALLIZING SORBITOL SOLUTION

Excipient focus: OCTOXYNOL-40

Excipient focus: OLIVE OIL

Excipient focus: POLOXAMER 188

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYGLYCERYL-10 OLEATE

Excipient focus: POLYGLYCERYL-3 OLEATE

Excipient focus: POLYOXYL 35 CASTOR OIL

Excipient focus: POLYOXYL 40 HYDROGENATED CASTOR OIL

CYCLOSPORINE drug variants containing POLYOXYL 40 HYDROGENATED CASTOR OIL

Company Ingredient NDC
AbbVie Inc cyclosporine 0074-7269
Novartis Pharmaceuticals Corporation cyclosporine 0078-0246
Teva Pharmaceuticals USA Inc cyclosporine 0093-5740
Teva Pharmaceuticals USA Inc cyclosporine 0093-9018
Teva Pharmaceuticals USA Inc cyclosporine 0172-7313
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc cyclosporine 23155-837
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: POLYSORBATE 80

Excipient focus: POLYVINYL ACETATE PHTHALATE

Excipient focus: POVIDONE K90

Excipient focus: PROPYLENE GLYCOL

Excipient focus: PROPYLENE GLYCOL MONOLAURATE

Excipient focus: SHELLAC

Excipient focus: SODIUM CHLORIDE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS

Excipient focus: SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE

Excipient focus: SORBITAN MONOOLEATE

Excipient focus: SORBITOL

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

CYCLOSPORINE drug variants containing TITANIUM DIOXIDE

Company Ingredient NDC
AbbVie Inc cyclosporine 0074-0541
Novartis Pharmaceuticals Corporation cyclosporine 0078-0240
Novartis Pharmaceuticals Corporation cyclosporine 0078-0246
Teva Pharmaceuticals USA Inc cyclosporine 0093-5740
Teva Pharmaceuticals USA Inc cyclosporine 0093-9018
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc cyclosporine 23155-837
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: TOCOPHEROL

Excipient focus: TYLOXAPOL

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links